Uber has a new system that allows physician offices to book rides for patients up to 30 days in advance.
These are the top 10 medical innovations expected to be seen in 2018.
The findings may help to better characterize normative development and altered patterns of brain activity that may serve as biomarkers for neurological conditions.
The CDC has updated the US national estimate of epilepsy prevalence and estimates 3.4 million people are affected by epilepsy.
Ketamine was found to alleviate a number of pain-related conditions, and a number of clinical trials investigating its efficacy are ongoing.
Jessica Karl, PA-C, of Rush University Medical Center in Chicago, discusses her research on the utility and feasibility of deep brain stimulation in patients with Huntington's disease. Scroll below the video for the full transcript.
Jaime Hatcher-Martin, MD, PhD, a movement disorders specialist at Emory University Hospital and the founder of Emory's movement disorders telemedicine clinic, shares her personal experience with telemedicine and provides some guidance for clinicians who might be interested in exploring this treatment option to improve their patients' access to care. Scroll below the video to read the full transcript.
Kara Smith, MD, a movement disorders specialist at UMass Memorial Medical Center and an assistant professor at the University of Massachusetts Medical School, both in Worcester, discusses how a brief free speech sample might be used to calculate a patient's cognitive and motor scores. Scroll below the video to read the full transcript.
Joohi Jimenez-Shahed, MD, discusses her research on the use of deutetrabenazine for the treatment of tardive dyskinesia in patients taking concomitant antipsychotics or neuroleptics. Scroll below the video for the full transcript.
Jori Fleisher, MD, MSCE, of New York University School of Medicine, discusses her research on an interdisciplinary home visit program for patients with advanced Parkinson's disease. Scroll below the video for the full transcript.
Central nervous system and neurologic involvement are common features of antiphospholipid syndrome.
Experts have turned their focus toward the potential role of the nervous system in migraine pathophysiology, as it is more ...
Neurology Advisor Articles
- Multiple System Atrophy: A Common Form of Atypical Parkinsonism
- Migraine Treatment in the ED: Overcoming Our Penchant for Opioids
- Oral Film Formulation of Clobazam Gets FDA Approval for LGS
- Erenumab as a Therapy for Hard to Treat Episodic Migraine
- Nusinersen May Be Effective for Short-Term Motor Function Improvements in Spinal Muscular Atrophy
- New Diagnostic Criteria for Neurosarcoidosis: What You Need to Know
- Guideline for Diagnosis and Treatment of Idiopathic Intracranial Hypertension
- Guidelines on the Use of OnabotulinumtoxinA for Chronic Migraine
- Ivy League Rule Change Linked to Fewer Concussions During NCAA Football Games
- Biomarkers of Alzheimer Disease Observed in Down Syndrome
- Ocrevus Labeling Updated With New Info on Timing of Vaccine Administration
- Approaches for Better Diagnosis of Pediatric Multiple Sclerosis
- Short Segment Sensory Nerve Stimulation Offers Potential Diagnostic Value for Ulnar Neuropathy
- Incidence of Guillain-Barré Syndrome Linked With Recent Bone, Digestive Organ Surgery
- Pharmacist-Led Effort Cuts Inappropriate Rx in Older Adults